Control of bone mass and remodeling by PTH receptor signaling in osteocytes |
| |
Authors: | O'Brien Charles A Plotkin Lilian I Galli Carlo Goellner Joseph J Gortazar Arancha R Allen Matthew R Robling Alexander G Bouxsein Mary Schipani Ernestina Turner Charles H Jilka Robert L Weinstein Robert S Manolagas Stavros C Bellido Teresita |
| |
Institution: | Division of Endocrinology, Center for Osteoporosis and Metabolic Bone Diseases, Central Arkansas Veterans Healthcare System, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America. caobrien@uams.edu |
| |
Abstract: | Osteocytes, former osteoblasts buried within bone, are thought to orchestrate skeletal adaptation to mechanical stimuli. However, it remains unknown whether hormones control skeletal homeostasis through actions on osteocytes. Parathyroid hormone (PTH) stimulates bone remodeling and may cause bone loss or bone gain depending on the balance between bone resorption and formation. Herein, we demonstrate that transgenic mice expressing a constitutively active PTH receptor exclusively in osteocytes exhibit increased bone mass and bone remodeling, as well as reduced expression of the osteocyte-derived Wnt antagonist sclerostin, increased Wnt signaling, increased osteoclast and osteoblast number, and decreased osteoblast apoptosis. Deletion of the Wnt co-receptor LDL related receptor 5 (LRP5) attenuates the high bone mass phenotype but not the increase in bone remodeling induced by the transgene. These findings demonstrate that PTH receptor signaling in osteocytes increases bone mass and the rate of bone remodeling through LRP5-dependent and -independent mechanisms, respectively. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|